Biosimilars: Key Regulatory Considerations and Similarity Assessment Tools

Biotechnology and Bioengineering - Germany
doi 10.1002/bit.26438
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Regulatory Considerations of Biosimilars and Clinical Dilema of Their Use

SANAMED
2017English

Coverage Analysis of Indonesia Sustainability Assessment Tools: Similarity in Dimension and Assessment Results

International Journal of Engineering and Technology(UAE)
ArchitectureHardwareEngineeringChemical EngineeringBiotechnologyEnvironmental EngineeringComputer Science
2018English

Assessing Early Learning Through Formative Assessment: Key Issues and Considerations

Irish Educational Studies
Education
2010English

Tools for Regulatory Assessment of Occupational Exposure: Development and Challenges

Journal of Exposure Science and Environmental Epidemiology
EpidemiologyPublic HealthEnvironmentalToxicologyPollutionOccupational Health
2007English

Comparative Immunogenicity Assessment of Biosimilars

Future Oncology
MedicineCancer ResearchOncology
2019English

Peak Exposures in Epidemiologic Studies and Cancer Risks: Considerations for Regulatory Risk Assessment

Risk Analysis
QualityReliabilitySafetyRiskPhysiology
2019English

Cannabis Vaping and Health: Regulatory Considerations

Addiction
MedicinePsychiatryMental Health
2019English

Aerobiology: Experimental Considerations, Observations, and Future Tools

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2017English

Php181 - Health Technology Assessment of Oncology Therapies in Spain and Italy: Key Metrics and Considerations

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy